Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
Clinical trial NCT07177092 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07177092
- Sponsor
- Jianxing He
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-08
- Primary completion
- 2028-10-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.